SCHEMBL342808

SCHEMBL342808

CCCCCC(CC)Oc1ccccc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
RECQL P46063 1/20 0.57
ALDH1A1 P00352 6/20 0.52
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
HSD17B10 Q99714 3/20 0.45
HPGD P15428 2/20 0.45
HTT P42858 2/20 0.45
TSHR P16473 4/20 0.44
ESR1 P03372 1/20 0.44
ITGB3 P05106 1/20 0.44
ITGA2B P08514 1/20 0.44
HMGB1 P09429 1/20 0.44
GGT1 P19440 1/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
BLM P54132 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11564477 0.99 KDM4E (0.56) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL9324896 0.99 KDM4E (0.56) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL27641227 0.94 KDM4E (0.57) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL15263303 0.93 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL3185045 0.93 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL2374608 0.93 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL5453802 0.93 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL10458043 0.93 KDM4E (0.58) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL2526219 0.91 KDM4E (0.57) KDM4EKMT2AMEN1RECQLALDH1A1
SCHEMBL368882 0.91 KDM4E (0.57) KDM4EKMT2AMEN1RECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1041 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12582588-B2 Solid cosmetic composition for blocking ultraviolet radiation having water resistance and cleansing properties LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2026-03-24 US claimed
US-12502348-B2 Ultraviolet blocking cosmetic composition in chromatic emulsion state LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2025-12-23 US claimed
US-20250360069-A1 SUNSCREEN COMPOSITION FOR LACTOBACILLUS AND S. EPIDERMIDIS PROTECTION ON SKIN DSM IP ASSETS BV (NL) 2025-11-27 US claimed
EP-3169304-B2 SPRAYABLE SUNSCREEN COMPOSITION WITH OIL BEADS OREAL (FR) 2025-06-11 EP claimed
EP-4401702-A1 USE OF FATTY ESTER AS A SOLUBILISING AGENT FOR FAT-SOLUBLE UV FILTER ARKEMA FRANCE (FR) 2024-07-24 EP claimed
EP-4344750-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION USEFUL FOR SUN PROTECTION OR SKIN CARE Rivet, Jean-Paul (FR) 2024-04-03 EP claimed
WO-2023242008-A1 SUNSCREEN COMPOSITION FOR LACTOBACILLUS AND S. EPIDERMIDIS PROTECTION ON SKIN DSM IP ASSETS B.V. (NL) 2023-12-21 WO claimed
US-20230233428-A1 SOLID COSMETIC COMPOSITION FOR BLOCKING ULTRAVIOLET RADIATION HAVING WATER RESISTANCE AND CLEANSING PROPERTIES LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2023-07-27 US claimed
WO-2023041869-A1 USE OF FATTY ESTER AS A SOLUBILISING AGENT FOR FAT-SOLUBLE UV FILTER ARKEMA FRANCE (FR) 2023-03-23 WO claimed
US-20220287951-A1 Ultraviolet Blocking Cosmetic Composition In Chromatic Emulsion State LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2022-09-15 US claimed
JP-2003534249-A 2003-11-18 JP claimed
EP-1335693-A2 COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS Sol-Gel Technologies Ltd. (IL) 2003-08-20 EP claimed
WO-2003039510-A1 COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER SOL-GEL TECHNOLOGIES LTD. (IL) 2003-05-15 WO claimed
WO-2003034979-A2 COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS SOL-GEL TECHNOLOGIES LTD. (IL) 2003-05-01 WO claimed
US-20020064541-A1 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients SOL-GEL TECHNOLOGIES LTD. (IL) 2002-05-30 US claimed
WO-2001080823-A2 COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TROPICAL ACTIVE INGREDIENTS SOL-GEL TECHNOLOGIES LTD. (IL) 2001-11-01 WO claimed
EP-0552289-A4 PREVENTION OR TREATMENT OF SUNBURN USING THE S(+) ISOMER OF KETOPROFEN 1993-08-11 EP claimed
EP-0552289-A1 PREVENTION OR TREATMENT OF SUNBURN USING THE S(+) ISOMER OF KETOPROFEN MILES INC. (US) 1993-07-28 EP claimed
WO-1992005769-A1 PREVENTION OR TREATMENT OF SUNBURN USING THE S(+) ISOMER OF KETOPROFEN MILES, INC. (US) 1992-04-16 WO claimed
US-4372583-A Chromogenic copy system and method VASSILIADES ANTHONY E 1983-02-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12582588-B2 Solid cosmetic composition for blocking ultraviolet radiation having water resistance and cleansing properties CUTA, TRPA1, ERCC5 KDM4E 3295/4885KMT2A 3913/4885MEN1 4599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.